Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201120 · ClinicalTrials.gov registry record · NA
Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 3,595
- Enrollment target
NCT03201120: Completed NA study, sponsored by University of Pennsylvania.
NCT03201120 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 3,595 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03201120, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,595 participants
- Enrollment target
Study Summary
Phase 3b of the research will be a laboratory experiment that uses an experimental and analytic design that is parallel to that used in Phase 3a, the online experiment. The primary objective of Phase 3b is to assess physiological response (i.e., eye tracking) to different message appeals of the audio-visual messages used in Phase 3a on respondents' behavioral intentions and UV-related behavioral choices post-exposure. Including time for preparation, viewing, and removal of the monitoring equipment, the message viewing session will take about 45 minutes per session.
Interventions
- BEHAVIORAL Outdoor Sun Behavior
- BEHAVIORAL Indoor Tanning Behavior
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,595 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2017-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03201120
The ClinicalTrials.gov registry entry for NCT03201120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,595 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Outdoor Sun Behavior is the first listed.
NCT03201120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03201120 about?
NCT03201120 is a clinical study titled "Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing". Phase 3b of the research will be a laboratory experiment that uses an experimental and analytic design that is parallel to that used in Phase 3a, the online experiment. The primary objective of Phase 3b is to assess physiological response (i.e., eye tracking) to different message appeals of the audi...
What is the current status of trial NCT03201120?
This trial is currently completed. It is a NA study. The enrollment target is 3,595 participants. The study started on 2017-03-29. Estimated completion is 2017-09-28.
What interventions are being tested in trial NCT03201120?
The interventions under investigation include: Outdoor Sun Behavior (BEHAVIORAL), Indoor Tanning Behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT03201120?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.